New Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel®. Read more

Sorry, this form is not available.

Your partner in patient-first care

Your partner in patient-first care

It’s a new day at Myriad, and for your practice. Together we can make genetic testing and data-driven medical information available to more patients than ever before with greater access, affordability and truly personalized insights. Now is the time to drive lasting healthcare transformation – and it’s within your grasp.

It’s a new day at Myriad, and for your practice. Together we can make genetic testing and data-driven medical information available to more patients than ever before with greater access, affordability and truly personalized insights. Now is the time to drive lasting healthcare transformation – and it’s within your grasp.

Patient care. Illuminated.

At Myriad, we’re committed to helping the more than 60,000 active ordering physicians just like you make a difference in the lives of their patients. Our Women’s Health solutions can help you do just that with:

Prenatal Screens

  • How Foresight® Carrier Screen gives patients all patients a reliable result with the highest published at-risk couple detection rates
  • How Prequel® Prenatal Screen gives patients of all BMIs a reliable result the first time

Hereditary Cancer Risk Assessment

  • How MyRisk® with RiskScore® goes beyond a positive/negative test result, blending a comprehensive assessment for hereditary cancer risk with the precision of genomic breast cancer risk assessment
  • How 56% of MyRisk patients qualify for medical management change vs. only 10% with most competitors1
  • How MyRisk with RiskScore is the only hereditary cancer test designed for patients of all ancestries

1 Myriad Internal Data based on OBGYN and Primary Care Settings, Sept 2019

Get started Get Started

Locations

United States
Europe
Japan